PE20110676A1 - COMPOUNDS DERIVED FROM ENFUMAFUNGIN WITH ANTIFUNGAL ACTIVITY - Google Patents
COMPOUNDS DERIVED FROM ENFUMAFUNGIN WITH ANTIFUNGAL ACTIVITYInfo
- Publication number
- PE20110676A1 PE20110676A1 PE2011000156A PE2011000156A PE20110676A1 PE 20110676 A1 PE20110676 A1 PE 20110676A1 PE 2011000156 A PE2011000156 A PE 2011000156A PE 2011000156 A PE2011000156 A PE 2011000156A PE 20110676 A1 PE20110676 A1 PE 20110676A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- enfumafungin
- ring
- spp
- referred
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- IAOFPTKYKOAKGZ-CRWQHXLTSA-N enfumafungin Chemical compound O([C@H]1[C@H](OC(C)=O)C[C@@]23C(O)OC[C@]1(C)[C@@H]2CC[C@@H]1[C@@]2(C)CC[C@]([C@H]([C@]2(C)CC=C13)C(O)=O)(C)[C@H](C)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IAOFPTKYKOAKGZ-CRWQHXLTSA-N 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 title 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- -1 AMINOCARBONYL Chemical class 0.000 abstract 1
- 241000228212 Aspergillus Species 0.000 abstract 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 abstract 1
- 229920001503 Glucan Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical group C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
REFERIDA A UN COMPUESTO DERIVADOS DE ENFUMAFUNGINA DE FORMULA I, DONDE X ES O,H; Re ES C(O)NRfRg, UN GRUPO HETEROARILO ANULAR DE 6 MIEMBROS QUE CONTIENE 1-2 ATOMOS DE N, DONDE HETEROARILO ES, OPCIONALMENTE MONO-SUSTITUIDO EN UN CARBONO DEL ANILLO CON F, Cl, N DEL ANILLO CON O; Rf, Rg, R6 Y R7 SON CADA UNO H, ALQUILO C1-C3; R8 ES ALQUILO C1-C4, CICLOALQUILO C3-C4, CICLOALQUIL-ALQUILO C1-C4; R9 ES METILO, ETILO, ENTRE OTROS. UN COMPUESTO PREFERIDO ES: (1S,4aR, 6aS,7R,8R,10aR,10bR,12aR,14R,15R)-14-[5-(AMINOCARBONIL)-1H-1,2,4-TRIAZOL-1-IL]-8-[(1R)-1,2-DIMETILPROPIL]-15-[[(2R)-2,3-DIMETIL-2-(METILAMINO)BUTIL]OXI]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-DODECAHIDRO-1,6a,8,10a-TETRAMETIL-4H-1,4a-PROPANO-2H-FENANTRO[1,2-c]PIRAN-7-ACIDO CARBOXILICO. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE (1,3)-BETA-DELTA-GLUCAN SINTASA, SIENDO UTILES EN EL TRATAMIENTO DE INFECCIONES FUNGICAS CAUSADAS POR HONGOS Cryptococcus spp, Candida spp O Aspergillus sppREFERRED TO A COMPOUND DERIVED FROM ENFUMAFUNGIN OF FORMULA I, WHERE X IS O, H; Re IS C (O) NRfRg, A 6-MEMBER HETEROARYL RING GROUP CONTAINING 1-2 N ATOMS, WHERE HETEROARYL IS, OPTIONALLY MONO-SUBSTITUTED IN A CARBON OF THE RING WITH F, Cl, N OF THE RING WITH O; Rf, Rg, R6 AND R7 ARE EACH H, C1-C3 ALKYL; R8 IS C1-C4 ALKYL, C3-C4 CYCLOALKYL, C1-C4 CYCLOALKYL ALKYL; R9 IS METHYL, ETHYL, AMONG OTHERS. A PREFERRED COMPOUND IS: (1S, 4aR, 6aS, 7R, 8R, 10aR, 10bR, 12aR, 14R, 15R) -14- [5- (AMINOCARBONYL) -1H-1,2,4-TRIAZOL-1-IL] -8 - [(1R) -1,2-DIMETHYLPROPYL] -15 - [[(2R) -2,3-DIMETHYL-2- (METHYLAMINE) BUTYL] OXY] -1,6,6a, 7,8,9 , 10,10a, 10b, 11,12,12a-DODECAHYDRO-1,6a, 8,10a-TETRAMETHYL-4H-1,4a-PROPANE-2H-PHENANTHRO [1,2-c] PYRAN-7-CARBOXYL ACID. ALSO REFERRED TO A PHARMACEUTICAL COMPOSITION. SAID COMPOUNDS ARE INHIBITORS OF (1,3) -BETA-DELTA-GLUCAN SYNTHASE, BEING USEFUL IN THE TREATMENT OF FUNGIC INFECTIONS CAUSED BY FUNGI Cryptococcus spp, Candida spp OR Aspergillus spp
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13610608P | 2008-08-12 | 2008-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20110676A1 true PE20110676A1 (en) | 2011-09-23 |
Family
ID=41669132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2011000156A PE20110676A1 (en) | 2008-08-12 | 2009-08-07 | COMPOUNDS DERIVED FROM ENFUMAFUNGIN WITH ANTIFUNGAL ACTIVITY |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP2326172B1 (en) |
| KR (1) | KR101686075B1 (en) |
| AR (1) | AR073037A1 (en) |
| BR (1) | BRPI0912074B1 (en) |
| CL (1) | CL2011000292A1 (en) |
| CO (1) | CO6351686A2 (en) |
| CR (1) | CR20110075A (en) |
| DK (1) | DK2326172T3 (en) |
| DO (1) | DOP2011000053A (en) |
| EA (1) | EA018337B1 (en) |
| ES (1) | ES2526652T3 (en) |
| GT (1) | GT201100039A (en) |
| HN (1) | HN2011000404A (en) |
| HR (1) | HRP20150009T1 (en) |
| IL (2) | IL210975A (en) |
| MA (1) | MA32628B1 (en) |
| MX (1) | MX2011001656A (en) |
| MY (1) | MY156955A (en) |
| NI (1) | NI201100035A (en) |
| NZ (1) | NZ590914A (en) |
| PE (1) | PE20110676A1 (en) |
| PL (1) | PL2326172T3 (en) |
| PT (1) | PT2326172E (en) |
| RS (1) | RS53731B1 (en) |
| SI (1) | SI2326172T1 (en) |
| SV (1) | SV2011003839A (en) |
| TW (1) | TWI439458B (en) |
| UA (1) | UA105639C2 (en) |
| WO (1) | WO2010019203A1 (en) |
| ZA (1) | ZA201100788B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4039684A1 (en) | 2015-01-19 | 2022-08-10 | Scynexis, Inc. | Novel salts and polymorphs of scy-078 |
| EA201992413A1 (en) | 2017-04-10 | 2020-03-16 | Сайнексис, Инк. | ANTI-FOAM AGENTS USED IN COMBINATION |
| HRP20221414T1 (en) * | 2017-08-04 | 2023-01-20 | Scynexis, Inc. | Antifungal agents with enhanced activity in acidic ph |
| MA54866A (en) * | 2019-01-30 | 2022-05-04 | Scynexis Inc | TRITERPENOID ANTIFUNGALS FOR THE TREATMENT OF FUNGAL OSTEOARTICULAR INFECTIONS |
| CN113905733A (en) * | 2019-05-16 | 2022-01-07 | 西尼克斯公司 | Antifungal agent such as erebephen herceptin for eliminating candida otic colonization |
| CN115811989A (en) | 2020-05-29 | 2023-03-17 | 法国国家科学研究中心 | antifungal prodrugs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2244142C (en) * | 1996-01-31 | 2005-03-29 | Merck & Co., Inc. | Antifungal compound from hormonema sp. |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| CN1705657A (en) | 2002-04-17 | 2005-12-07 | 兰贝克赛实验室有限公司 | Azole derivatives as antifungal agents |
| US7863465B2 (en) * | 2006-04-03 | 2011-01-04 | Merck Sharp & Dohme Corp. | Antifungal agents |
-
2009
- 2009-08-07 EA EA201100350A patent/EA018337B1/en unknown
- 2009-08-07 SI SI200931102T patent/SI2326172T1/en unknown
- 2009-08-07 HR HRP20150009AT patent/HRP20150009T1/en unknown
- 2009-08-07 UA UAA201102860A patent/UA105639C2/en unknown
- 2009-08-07 PE PE2011000156A patent/PE20110676A1/en active IP Right Grant
- 2009-08-07 PT PT98069446T patent/PT2326172E/en unknown
- 2009-08-07 MX MX2011001656A patent/MX2011001656A/en active IP Right Grant
- 2009-08-07 EP EP09806944.6A patent/EP2326172B1/en active Active
- 2009-08-07 BR BRPI0912074-2A patent/BRPI0912074B1/en active IP Right Grant
- 2009-08-07 PL PL09806944T patent/PL2326172T3/en unknown
- 2009-08-07 MY MYPI2011000483A patent/MY156955A/en unknown
- 2009-08-07 WO PCT/US2009/004557 patent/WO2010019203A1/en not_active Ceased
- 2009-08-07 NZ NZ590914A patent/NZ590914A/en unknown
- 2009-08-07 RS RS20150006A patent/RS53731B1/en unknown
- 2009-08-07 KR KR1020117005837A patent/KR101686075B1/en active Active
- 2009-08-07 DK DK09806944.6T patent/DK2326172T3/en active
- 2009-08-07 ES ES09806944.6T patent/ES2526652T3/en active Active
- 2009-08-10 TW TW098126822A patent/TWI439458B/en active
- 2009-08-12 AR ARP090103123A patent/AR073037A1/en active IP Right Grant
-
2011
- 2011-01-31 IL IL210975A patent/IL210975A/en active IP Right Grant
- 2011-01-31 ZA ZA2011/00788A patent/ZA201100788B/en unknown
- 2011-02-08 CR CR20110075A patent/CR20110075A/en unknown
- 2011-02-10 NI NI201100035A patent/NI201100035A/en unknown
- 2011-02-11 CO CO11016262A patent/CO6351686A2/en active IP Right Grant
- 2011-02-11 GT GT201100039A patent/GT201100039A/en unknown
- 2011-02-11 SV SV2011003839A patent/SV2011003839A/en active IP Right Grant
- 2011-02-11 CL CL2011000292A patent/CL2011000292A1/en unknown
- 2011-02-11 HN HN2011000404A patent/HN2011000404A/en unknown
- 2011-02-11 DO DO2011000053A patent/DOP2011000053A/en unknown
- 2011-03-11 MA MA33691A patent/MA32628B1/en unknown
-
2015
- 2015-10-12 IL IL242031A patent/IL242031A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20110676A1 (en) | COMPOUNDS DERIVED FROM ENFUMAFUNGIN WITH ANTIFUNGAL ACTIVITY | |
| AR076360A1 (en) | DERIVATIVES OF 3,3'-ESPIROINDOLINONA AND ITS USE IN THE TREATMENT OF CANCER | |
| RU2448976C2 (en) | Hcv/hiv inhibitors and their application | |
| PE20080131A1 (en) | ANTIFUNGAL AGENTS | |
| ECSP20044709A (en) | CARDIAC SARCOMER INHIBITORS | |
| ES2600636T3 (en) | Spiro- [1,3] -oxazines and spiro- [1,4] -oxazepines as inhibitors of BACE1 and / or BACE2 | |
| PE20061073A1 (en) | COMPOUNDS DERIVED FROM PIPERIDINYLAMIDE AS INHIBITING AGENTS OF KINASES | |
| NZ703495A (en) | Inhibitors of the fibroblast growth factor receptor | |
| PE20121356A1 (en) | SYNERGIC FUNGICIDE COMBINATIONS CONTAINING A FUNGICIDE DITIINE-TETRACARBOXIMIDE | |
| CL2018002358A1 (en) | Pyrazolo derivatives [1,5-a] pyrazin-4-yl | |
| PE20121815A1 (en) | PIRROLO-PYRIMIDINE COMPOUNDS AS CDK4 / 6 INHIBITORS | |
| BRPI1009333B8 (en) | beta-secretase inhibitor compounds, their uses, as well as pharmaceutical composition | |
| PE20151063A1 (en) | SUBSTITUTE DERIVATIVE OF SPIROPYRIDE [1,2-a] PIRAZINE AND MEDICAL USE OF THE SAME AS AN INHIBITOR OF HIV INTEGRASE | |
| AR071283A1 (en) | HETEROCICLICAL COMPOUNDS AND USES OF THE SAME | |
| PH12012501030A1 (en) | Anti-tumor effect potentiator | |
| MX2012010966A (en) | Pharmaceutically active disubstituted triazine derivatives. | |
| PE20200793A1 (en) | SUBSTITUTED BICYCLIC KETONE COMPOUNDS, AS RIP1 KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
| PE20142366A1 (en) | TRIAZOLO COMPOUNDS AS PDE INHIBITORS 10 | |
| CO6150181A2 (en) | COMPOUND 6- (BENCILO REPLACED WITH HETEROCICLE) -4-OXOQUINOLINE AND ITS USE AS AN INTEGRASA HIV INHIBITOR | |
| CO6190612A2 (en) | HETEROCICLIC DERIVATIVES AS M3 MUSCARINIC RECEPTORS | |
| CO2020016080A2 (en) | Compounds | |
| PE20220376A1 (en) | TRICYCLIC COMPOUNDS AND THEIR USE | |
| UY37764A (en) | NEW INHIBITING COMPOUNDS OF PROSTAGLANDINA D SINTASA HEMATOPOYÉTICA (H-PGDS) | |
| PH12018502012A1 (en) | Griseofulvin compound | |
| AR094123A1 (en) | TRICYCLE COMPOUND |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |